PSA Density Calculator
Enter your prostate measurements from an ultrasound or MRI report and your serum PSA level to calculate PSA density (PSAD). PSAD adjusts raw PSA for prostate size, helping distinguish cancer-related PSA elevation from benign prostatic enlargement. Results include prostate volume, PSAD, and age-specific risk context based on current urology guidelines.
Formula
Worked example
A 62-year-old man has a prostate measuring 4.5 cm x 4.2 cm x 3.8 cm on MRI and a serum PSA of 5.5 ng/mL. Ellipsoid volume = 4.5 x 4.2 x 3.8 x 0.52 = 37.4 mL. PSAD = 5.5 / 37.4 = 0.147 ng/mL/mL. The age-adjusted threshold for men aged 60-69 is 0.20, so this result is borderline but below the age-specific limit. The standard clinical threshold of 0.15 is nearly met, indicating that further evaluation (typically multiparametric MRI) is appropriate.
What is PSA density and why does it matter?
Prostate-specific antigen (PSA) is a protein produced by prostate cells, and some of it enters the bloodstream where it can be measured. Both cancerous and non-cancerous prostate tissue produce PSA, so a raised PSA does not automatically mean cancer: a larger prostate simply makes more PSA even when perfectly benign. PSA density (PSAD) corrects for this by dividing the serum PSA by the prostate volume. A man with a serum PSA of 6 ng/mL and a 70 mL prostate has a PSAD of 0.086, which is reassuringly low. The same PSA in a man with a 25 mL prostate gives a PSAD of 0.24, which is more concerning, because that smaller gland should not be producing that much PSA. PSAD therefore helps clinicians separate the signal (cancer) from the noise (benign enlargement), reducing unnecessary biopsies while still identifying men who genuinely need further investigation.
How prostate volume is estimated from imaging
Radiologists measure three perpendicular diameters of the prostate on ultrasound or MRI: the anteroposterior (AP, front-to-back) length, the transverse (left-to-right) width, and the craniocaudal (head-to-toe) height. The standard ellipsoid formula multiplies these three dimensions by 0.52 (which equals pi/6, the same constant used to estimate the volume of a perfect ellipsoid). This method is accurate for the typical oval-shaped prostate. For smaller or more spherical glands, some radiologists prefer the bullet formula, which uses a constant of 0.65 and tends to give a slightly larger volume estimate. Using the right formula matters because the volume goes directly into the PSAD denominator: a 25 percent difference in the constant changes the PSAD by 25 percent in the other direction. Always confirm which formula your radiology report used before comparing results.
How to interpret your PSAD result
The most widely cited threshold is 0.15 ng/mL/mL: values at or above this level are associated with a meaningfully higher probability of clinically significant prostate cancer, and most major urology guidelines use this cut-off when deciding whether to recommend biopsy in men with an otherwise equivocal PSA result. A PSAD below 0.10 is generally considered reassuring, particularly when a multiparametric MRI of the prostate is also negative (PI-RADS 1 or 2). The zone between 0.10 and 0.15 is borderline and is typically managed by combining PSAD with other information: PSA velocity (how fast PSA is rising), the free-to-total PSA ratio, MRI findings (PI-RADS score), and individual risk factors such as family history or African ancestry. Age matters too: PSA and prostate volume both rise with age, so the absolute threshold that triggers concern is somewhat higher in older men.
PSAD limitations and what else to consider
PSAD improves on raw PSA, but it is not a definitive diagnostic test. Prostate volume estimates vary by imaging modality, operator technique, and the formula used. Measurement errors of even a few millimetres can shift the volume by 10-20 percent, which changes the PSAD accordingly. Certain medicines such as 5-alpha-reductase inhibitors (finasteride, dutasteride) suppress PSA by roughly half, so the measured PSA should be doubled before calculating PSAD if you take them. The transition-zone PSA density (PSA divided by the inner gland volume alone) has been shown in some studies to discriminate better than whole-gland PSAD, though it is less commonly used in routine practice. PSAD is best interpreted alongside a complete clinical picture: digital rectal examination findings, PSA kinetics, MRI PI-RADS category, patient age, and shared-decision discussions with a urologist.
Age-adjusted PSA density thresholds
| Age group | PSAD threshold (ng/mL/mL) | Clinical action |
|---|---|---|
| Under 50 | ≤ 0.10 | Routine monitoring |
| 50-59 | ≤ 0.15 | Routine monitoring |
| 60-69 | ≤ 0.20 | Routine monitoring |
| 70 and over | ≤ 0.25 | Routine monitoring |
| Any age | > age threshold | Consider urological evaluation |
| Any age | ≥ 0.15 | Biopsy often considered (standard threshold) |
Upper normal PSAD limits by age group, based on European Association of Urology 2023 guidelines and published clinical data. Values above these thresholds generally prompt urological evaluation.
Frequently asked questions
What is a normal PSA density?
Most urology guidelines use a PSAD of 0.15 ng/mL/mL as the key threshold for clinical action. Values below 0.10 are generally considered low-risk. Because the prostate grows with age, the level that raises concern is somewhat higher in older men (around 0.20 in the 60s and 0.25 for men over 70), but the standard 0.15 cut-off remains the most commonly cited benchmark for biopsy decisions.
What PSA density indicates cancer?
No single PSAD value confirms or rules out cancer. A PSAD at or above 0.15 ng/mL/mL is associated with a significantly higher probability of clinically significant prostate cancer compared to lower values. Studies have found that men with PSAD below 0.09 have roughly a 4 percent chance of harboring clinically significant disease, while those above 0.15 have a substantially higher probability. A result above 0.15 is a reason for further evaluation, not a diagnosis.
Can I use my PSA result without knowing my prostate volume?
Not for PSA density. PSAD requires prostate volume, which is measured by ultrasound or MRI. If you only have a serum PSA result, you can discuss with your doctor whether imaging is appropriate for your situation. Standard PSA cut-offs (typically 4.0 ng/mL for men under 70) are used when volume data is not available, but they have lower specificity than PSAD.
Why does the formula used (ellipsoid vs. bullet) matter?
The two formulas give different volume estimates for the same three dimensions. The ellipsoid constant (0.52) is standard for most prostates. The bullet constant (0.65) is larger, so it produces a higher volume estimate, which in turn lowers the calculated PSAD. Using the wrong formula could make a borderline PSAD look either more or less concerning than it actually is. The formula your radiologist used is usually stated in the report or can be asked about directly.
Does taking finasteride or dutasteride affect my PSAD?
Yes. These medications, which are used to treat benign prostatic enlargement, suppress PSA production by about 50 percent after 6-12 months of use. If you take them, your measured PSA should be doubled before calculating PSAD to get a value comparable to someone who is not on these drugs. Always tell your doctor and any calculator you use if you take 5-alpha-reductase inhibitors.
Is a high PSAD an automatic reason for a biopsy?
Not automatically. A PSAD above the threshold is one input in a shared clinical decision that also considers MRI findings, PSA velocity, free-to-total PSA ratio, your age, family history, and your personal preferences about biopsy risks versus the risk of missing cancer. Many guidelines now recommend multiparametric MRI as an intermediate step before biopsy when PSAD is borderline or elevated.
How is PSAD different from free PSA ratio?
Free PSA ratio (free PSA divided by total PSA, expressed as a percentage) is another refinement of raw PSA. Cancer cells tend to produce more complex, bound forms of PSA, so a lower free percentage (typically below 10-25 percent, depending on the threshold used) raises concern. PSAD adjusts for gland size; free PSA ratio adjusts for the biological form of PSA. Both are complementary tools that a urologist may use together to sharpen the assessment.